Overview

Islet Transplantation Using Abatacept

Status:
Completed

Trial end date:
2014-12-01

Target enrollment:

Participant gender:

Summary

Islet transplantation in type 1 diabetics with hypoglycemic unawareness using abatacept as a part of a novel calcineurin-inhibitor-sparing immunosuppressive regimen.

Phase:

Phase 2

Details

Lead Sponsor:

Emory University

Collaborator:

Juvenile Diabetes Research Foundation

Treatments:

Abatacept
Antibodies, Monoclonal